Clinical Trial Update: Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sodium bicarbonate to reduce contrast-induced chronic kidney injury was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Drugs mentioned

• Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: MD Scientific | Conditions: Contrast Induced Kidney Injury. | Phase 3 | Status: TERMINATED